These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2995021)
1. Effect of naloxone on the hormone response to CRF in normal man. Conaglen JV; Donald RA; Espiner EA; Livesey JH; Nicholls MG Endocr Res; 1985; 11(1-2):39-44. PubMed ID: 2995021 [TBL] [Abstract][Full Text] [Related]
2. The effect of ovine corticotropin-releasing factor on catecholamine, vasopressin, and aldosterone secretion in normal man. Conaglen JV; Donald RA; Espiner EA; Livesey JH; Nicholls MG J Clin Endocrinol Metab; 1984 Mar; 58(3):463-6. PubMed ID: 6319453 [TBL] [Abstract][Full Text] [Related]
3. Plasma adrenocorticotrophin, cortisol and aldosterone responses to ovine corticotrophin-releasing factor and vasopressin in sheep. Pradier P; Davicco MJ; Safwate A; Tournaire C; Dalle M; Barlet JP; Delost P Acta Endocrinol (Copenh); 1986 Jan; 111(1):93-100. PubMed ID: 3004095 [TBL] [Abstract][Full Text] [Related]
4. Augmentation of the response to CRF in man: relative contributions of endogenous angiotensin and vasopressin. Milsom SR; Conaglen JV; Donald RA; Espiner EA; Nicholls MG; Livesey JH Clin Endocrinol (Oxf); 1985 May; 22(5):623-9. PubMed ID: 2992846 [TBL] [Abstract][Full Text] [Related]
5. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides. Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596 [TBL] [Abstract][Full Text] [Related]
6. Pituitary peptides other than ACTH may not be aldosterone secretagogue in primary aldosteronism. Miyamori I; Koshida H; Matsubara T; Soma R; Takasaki H; Okamoto S; Takeda R Exp Clin Endocrinol; 1990 Aug; 95(3):323-9. PubMed ID: 2174003 [TBL] [Abstract][Full Text] [Related]
8. Pituitary and adrenal hormone responses to naloxone in euhydrated and dehydrated dogs. Wade CE Am J Physiol; 1985 Dec; 249(6 Pt 1):E634-8. PubMed ID: 3002181 [TBL] [Abstract][Full Text] [Related]
9. The physiological significance of arginine vasopressin in potentiating the response to corticotrophin-releasing factor in sheep. Redekopp C; Livesey JH; Sadler W; Donald RA J Endocrinol; 1986 Feb; 108(2):309-12. PubMed ID: 3005462 [TBL] [Abstract][Full Text] [Related]
10. The effect of immersion in water on the levels of plasma renin activity and aldosterone, vasopressin, ACTH, cortisol, adrenaline and noradrenaline in serum of persons with simple obesity. Szurkowski M; Daniel K; Kokot F; Grzeszczak W Mater Med Pol; 1988; 20(3):150-5. PubMed ID: 2854182 [No Abstract] [Full Text] [Related]
11. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man. Inder WJ; Ellis MJ; Evans MJ; Donald RA Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616 [TBL] [Abstract][Full Text] [Related]
12. Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism. Miyamori I; Yasuhara S; Matsubara T; Okamoto S; Ikeda M; Koshida H; Morise T; Takeda Y; Takeda R; Vecsei P Endocrinol Jpn; 1987 Dec; 34(6):809-19. PubMed ID: 2836182 [TBL] [Abstract][Full Text] [Related]
13. Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Ehrenreich H; Schuck J; Stender N; Pilz J; Gefeller O; Schilling L; Poser W; Kaw S Alcohol Clin Exp Res; 1997 Oct; 21(7):1285-93. PubMed ID: 9347091 [TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations of adrenocorticotropin-related peptides in lambs injected with ovine corticotropin releasing factor or vasopressin. Pradier P; Tournaire C; Dalle M; Delost P J Dev Physiol; 1989 Feb; 11(2):103-9. PubMed ID: 2550539 [TBL] [Abstract][Full Text] [Related]
15. Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol. Orth DN; Jackson RV; DeCherney GS; DeBold CR; Alexander AN; Island DP; Rivier J; Rivier C; Spiess J; Vale W J Clin Invest; 1983 Mar; 71(3):587-95. PubMed ID: 6298280 [TBL] [Abstract][Full Text] [Related]
16. Corticotropin releasing factor activity of CRF 41 in normal man is potentiated by angiotensin II and vasopressin but not by desmopressin. Gaillard RC; Riondel AM; Ling N; Muller AF Life Sci; 1988; 43(23):1935-44. PubMed ID: 2849011 [TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders. Nakahara M; Shibasaki T; Shizume K; Kiyosawa Y; Odagiri E; Suda T; Yamaguchi H; Tsushima T; Demura H; Maeda T J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867 [TBL] [Abstract][Full Text] [Related]
18. Plasma ACTH, cortisol and aldosterone concentrations in chronically cannulated ovine fetuses and in lambs injected with ovine corticotropin releasing factor. Pradier P; Dalle M; Davicco MJ; Lefaivre J; Barlet JP; Delost P J Dev Physiol; 1985 Aug; 7(4):259-68. PubMed ID: 2995476 [TBL] [Abstract][Full Text] [Related]
19. Pituitary and adrenal responses to ovine corticotropin releasing factor and vasopressin injected into young and adult guinea-pigs. Pradier P; Tournaire C; Dalle M J Dev Physiol; 1990 Sep; 14(3):163-9. PubMed ID: 1966108 [TBL] [Abstract][Full Text] [Related]
20. Responses of plasma adrenocorticotropin and cortisol to intravenous injection of synthetic ovine corticotropin releasing factor in the morning and early evening in normal human subjects. Watabe T; Tanaka K; Hasegawa M; Miyabe S; Shimizu N Endocrinol Jpn; 1985 Oct; 32(5):771-9. PubMed ID: 3004929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]